rufigallol has been researched along with Malaria, Falciparum in 2 studies
*Malaria, Falciparum: Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beteck, RM; Legoabe, LJ; Patel, OPS | 1 |
| Ghatpande, SS; Kamath, VR; Mahajan, SS | 1 |
1 review(s) available for rufigallol and Malaria, Falciparum
| Article | Year |
|---|---|
Antimalarial application of quinones: A recent update.
Topics: Antimalarials; Dose-Response Relationship, Drug; Malaria, Falciparum; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinones; Structure-Activity Relationship | 2021 |
1 other study(ies) available for rufigallol and Malaria, Falciparum
| Article | Year |
|---|---|
Synergistic antimalarial activity of ketones with rufigallol and vitamin C.
Topics: Animals; Anthraquinones; Antimalarials; Antioxidants; Ascorbic Acid; Benzophenones; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Ketones; Malaria; Malaria, Falciparum; Mice; Parasitic Sensitivity Tests; Plasmodium berghei; Treatment Outcome | 2005 |